Drag a card by its title · ⚙ to size, swap or remove

The company

Myriad Genetics, Inc.

MYGN · Nasdaq

Health CareDiagnostics & LabsNot moving yet

MYGN stood above a rising 150-day average in 4 of the last 52 weekly readings, and has been out of that trend for the last 40 weeks. It is 9.2% below that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 40
Industry in uptrend: 48% -2 in 4 wk
Insider buys, 12 months: $1.4M
Insider sales, 12 months: $134K
Officials’ trades on record: 1
Institutions holding: 182 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 52 weeks.

17 Apr – 16 Oct

Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 0, Senate 0, executive 1; 1 people.

Who	Did	Amount	Traded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	sold	$15k–$50k	23 Mar 2026filed 14 May 2026

Insiders

Buy orders, 12 months5

Sale orders, 12 months1

Buyers · sellers3 · 1

Who	Did	Shares	Traded
Rashmi KumarDirector	sold	15,000at $4.46	8 Jun 2026filed 9 Jun 2026
Paul BisaroDirector	bought	7,500at $3.69	14 May 2026filed 14 May 2026
Samraat S. RahaPresident and CEO	bought	40,000at $5.00	9 Mar 2026filed 9 Mar 2026
S. Louise PhanstielDirector	bought	48,000at $4.66	27 Feb 2026filed 27 Feb 2026
S. Louise PhanstielDirector	bought	50,407at $4.80	26 Feb 2026filed 27 Feb 2026
S. Louise PhanstielDirector	bought	6,100at $4.74	25 Feb 2026filed 27 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders182-2 on the quarter

New · exited44 · 46

Reported value$495.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	10,890,440$62.2M	+2,000,796+22.5%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026	6,620,372$37.8M	-48,445−0.7%
Vestal Point Capital, LPadded · filed 14 Aug 2026	5,735,000$32.7M	+4,087,000+248.0%
STATE STREET CORPadded · filed 7 Aug 2026	4,985,060$28.5M	+561,033+12.7%
D. E. Shaw & Co., Inc.added · filed 14 Aug 2026	4,582,083$26.2M	+82,359+1.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,081,376$23.3M	+156,851+4.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	3,079,670$17.6M	+497,439+19.3%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026	2,766,689$15.8M	+854,393+44.7%
MORGAN STANLEYreduced · filed 13 Aug 2026	2,481,104$14.2M	-687,638−21.7%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	2,416,197$13.8M	+96,818+4.2%